Correlation Between Increased Total Serum IgE Levels and Clinical Features in Alopecia Areata Patients

This study examined the relationship between total serum IgE levels and clinical features in 436 alopecia areata (AA) patients compared to 181 healthy controls. It found that 31% of AA patients had elevated IgE levels, which were more common in males, children, and those with moderate-to-severe AA. Patients with alopecia universalis or totalis had higher IgE levels than those with localized AA. The study suggests that IgE and Th2 cytokines may play a role in AA pathogenesis and that IgE could serve as a marker for disease susceptibility and severity. It also highlights the potential of therapies targeting IgE and type 2 inflammation, such as dupilumab, for AA patients with elevated IgE levels. Further research is needed to explore these therapeutic options and the underlying pathogenesis of IgE level differences among AA subtypes.